BIO Endorses Senate SBIR Reauthorization Bill -- Co-Sponsors Sought

.
They said it couldn't be done! Impossible. Never happen. But it did!

The SBIR Advocacy and the Biotechnology Industry Organization (BIO) agree on an SBIR Reauthorization bill!

In a unanimous endorsement, the Senate Small Business and Entrepreneurship (SBE) Committee passed S.1233 up to the full Senate for consideration yesterday.

BIO immediately endorsed it too, joining the SBTC in recommending its passage!

In an article that appeared on GenomeWeb.com moments after the SBE Committee's action was announced, Jim Greenwood, BIO's CEO, is cited as having lauded the Bill! That's not to say that BIO won't promote amendments, but lauding is lauding! Guess we'll just have to wait and see what ensues in the full Senate debate.

Greenwood is quoted as urging Congress to reauthorize the SBIR program "as soon as possible in a way that provides a level playing field." Oh, really? Sort of ironic, eh what! A tip of my hat to you, JG! I appreciate chutzpah, being somewhat unabashed myself!

And, way to go, SBE Committee! And especially, thank you Senators Landrieu and Snowe for leading the way on this.

OK, let's get S.1233 Co-Sponsors lined up! If we can show overwhelming bi-partisan support for this Bill, there will be intense pressure put on the House to conform to it.

There's a Call to Action for enlisting S.1233 Co-Sponsors on the www.SBIRreauthorization.com website.

You'll find a model letter, links to Senatorial contact information, and a copy of the GenomeWeb article to attach.

Any questions? OK, team, let's get busy! Everybody's in the game! Fax letters, make calls.

We can do this. Nothing is impossible. It just takes a little longer!
.